Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 19 Breast Neoplasms 18 Fallopian Tube Neoplasms 13 Neoplasm Metastasis 10 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 7 Neoplasms 7 Endometrial Neoplasms 6 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neuroendocrine Tumors 3 Metastatic Castration-resistant Prostate Cancer 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Sarcoma 2 Recurrence 2 Pheochromocytoma 2 Paraganglioma 2 Osteosarcoma 2 Neuroblastoma 2 Multiple Myeloma 2 Medulloblastoma 2 Glioma 2 Glioblastoma 2 Ependymoma 2

Interventions

cabozantinib 5 Nivolumab 4 Ipilimumab 4 Axitinib 4 pembrolizumab 3 Blood Specimen Collection 3 zimberelimab 2 atezolizumab 2 Surveys and Questionnaires 2 Sunitinib 2 Irinotecan 2 temsirolimus 1 spartalizumab 1 salicylhydroxamic acid 1 palbociclib 1 orellanine 1 olaparib 1 liposomal doxorubicin 1 lenvatinib 1 gallium Ga 68 dotatate 1 fludarabine 1 brodalumab 1 belzutifan 1 aldesleukin 1 adagrasib 1 Vincristine 1 Temozolomide 1 Taxes 1 Selenomethionine 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × olaparib × 90 days × Clear all

NCT03786796 2026-03-30

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡